Quadrant Capital Group LLC Agios Pharmaceuticals, Inc. Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 100 shares of AGIO stock, worth $3,446. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100

Previous 100 -0.0%

Holding current value

$3,446

Previous $4,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$27.55 - $48.83 $743 - $1,318	27 Added 36.99%	100 $4,000
Q1 2024 May 15, 2024	SELL	$21.32 - $34.81 $277 - $452	-13 Reduced 15.12%	73 $2,000
Q4 2023 Feb 08, 2024	SELL	$19.97 - $24.53 $399 - $490	-20 Reduced 18.87%	86 $1,000
Q3 2023 Nov 14, 2023	SELL	$24.36 - $28.18 $633 - $732	-26 Reduced 19.7%	106 $2,000
Q2 2023 Aug 09, 2023	BUY	$21.38 - $29.19 $983 - $1,342	46 Added 53.49%	132 $3,000
Q1 2023 May 11, 2023	BUY	$21.74 - $30.93 $304 - $433	14 Added 19.44%	86 $1,000
Q4 2022 Feb 10, 2023	SELL	$24.81 - $31.52 $7,666 - $9,739	-309 Reduced 81.1%	72 $2,000
Q3 2022 Nov 10, 2022	BUY	$19.51 - $34.14 $273 - $477	14 Added 3.81%	381 $11,000
Q2 2022 Aug 09, 2022	BUY	$17.06 - $31.42 $5,544 - $10,211	325 Added 773.81%	367 $8,000
Q1 2022 May 06, 2022	BUY	$26.68 - $34.81 $80 - $104	3 Added 7.69%	42 $1,000
Q4 2021 Feb 01, 2022	SELL	$29.58 - $49.78 $1,715 - $2,887	-58 Reduced 59.79%	39 $1,000
Q3 2021 Nov 12, 2021	BUY	$41.92 - $58.18 $461 - $639	11 Added 12.79%	97 $4,000
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $1,793 - $2,513	54 Added 168.75%	86 $4,000
Q3 2020 Nov 13, 2020	BUY	$33.87 - $55.93 $440 - $727	13 Added 68.42%	32 $1,000
Q2 2020 Aug 13, 2020	SELL	$34.45 - $53.48 $19,636 - $30,483	-570 Reduced 96.77%	19 $1,000
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $3,624 - $6,188	115 Added 24.26%	589 $21,000
Q4 2019 Feb 03, 2020	BUY	$30.08 - $50.59 $14,257 - $23,979	474 New	474 $22,000
Q3 2019 Oct 24, 2019	SELL	$32.4 - $49.58 $356 - $545	-11 Closed	0 $0
Q2 2019 Jul 24, 2019	SELL	$46.17 - $68.1 $4,847 - $7,150	-105 Reduced 90.52%	11 $0
Q1 2019 Apr 29, 2019	BUY	$45.92 - $67.67 $5,326 - $7,849	116 New	116 $7,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Agios Pharmaceuticals, Inc. Transaction History